Agilent Technologies Stock - Analyst views after recent earnings beat
22.06.2026 - 08:22:34 | ad-hoc-news.deEdited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/22/2026, 08:21 CET. Details in the imprint.
Agilent Technologies (US00846U1016) drew fresh attention from equity research desks after its most recent quarter delivered an earnings beat and a guidance increase. According to a detailed analysis of the post-earnings reaction, some analysts now argue that the stock trades at a discount to their estimated fair value.
All news and analysis on Agilent Technologies stock
On our Agilent Technologies stock topic page you will find further background, historical news and market data on the life-science tools company.
What recent reports highlight
In its latest quarterly release, Agilent reported revenue and earnings ahead of analyst expectations, while also lifting its full-year guidance for the current fiscal year, according to company commentary summarized in the post-earnings coverage on financial platforms.
The same coverage notes that the stock was recently trading around $127 per share, while one valuation model cited a fair value estimate in the low $160s, implying a potential discount of roughly 20% for patient investors focused on long-term cash flows.
Analyst consensus on a Monday
Across Wall Street, consensus data compiled by major financial data providers point to a predominantly positive stance on Agilent Technologies, with most brokers rating the stock at Buy or equivalent and a smaller group remaining at Hold after the latest earnings update.
Average 12-month price targets in those compilations typically sit above the recent share price, underlining that analysts still expect earnings growth from demand in life-science, diagnostics and chemical analysis markets, even as macroeconomic visibility remains mixed.
How the company makes money
Agilent Technologies generates most of its revenue from laboratory instruments, consumables and related services used in life sciences, diagnostics and applied chemical markets, including chromatography systems, mass spectrometers, sample preparation products and software used by research labs and regulated industries worldwide.
Where the stock trades today
The shares of Agilent Technologies (US00846U1016) trade on the New York Stock Exchange at $127.49 as of 06/18/2026, 15:59 Eastern Time.
Key facts on Agilent Technologies stock
- Company: Agilent Technologies Inc.
- ISIN: US00846U1016
- WKN: 929921
- Ticker: A
- Venue: NYSE
- Price (as of 06/18/2026, 15:59 Eastern Time): 127.49 USD
- Market cap: 37,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care - Life Sciences Tools & Services
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
